WIO 2024: Conditional metastasis-free survival of uveal melanoma based on tumor size category
Source: Modern Retina , August 2024
In this study, the investigators retrospectively analyzed the incidence of metastasis in 8,034 patients with uveal melanoma over a 35-year period based on tumor size category.
Rolika Bansal, MD, and colleagues reported that the smaller the uveal melanoma tumor, the better the prognosis and the longer the patient lives, the risk of metastasis decreases across all the tumor size categories with lower likelihood of long-term metastasis. She is from the Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, and reported the findings of their project at the Women In Ophthalmology annual meeting in Carlsbad, CA.
The study rationale, according to the authors, is that tumor size is measurable and available for most patients with known information about a correlation between tumor size category and patient prognosis; however, the long-term conditional metastasis-free survival remains unknown and may provide insights for patient counseling.